Briacell Therapeutics Corp. Common Shares (BCTX) is a publicly traded Healthcare sector company. As of May 21, 2026, BCTX trades at $3.98 with a market cap of $24.29M and a P/E ratio of -0.06. BCTX moved +9.69% today. Year to date, BCTX is -49.28%; over the trailing twelve months it is -89.10%. Its 52-week range spans $2.98 to $214.50. Rallies surfaces BCTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BCTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BCTX recently traded at $3.98. Market cap is $24.29M. P/E ratio is -0.06. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $3.98 |
| Market Cap | $24.29M |
| P/E Ratio | -0.06 |
| EPS | $-62.19 |
| Dividend Yield | 0.00% |
| 52-Week High | $214.50 |
| 52-Week Low | $2.98 |
| Volume | 1.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.56M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-26.56M | $-62.19 |
| 2024 | $0 | $-4.93M | $-0.29 |
| 2023 | $0 | $-20.30M | $-1.30 |
| 2022 | $0 | $-26.84M | $-1.73 |
BCTX analyst coverage data. Average price target: $0.00.